Respicorder device development

Respicorder设备开发

• 批准号: 44925
• 金额: $ 16.66万
• 依托单位: ARETE MEDICAL TECHNOLOGIES LTD
• 依托单位国家: 英国
• 项目类别: Study
• 财政年份: 2020
• 资助国家: 英国
• 起止时间: 2020 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=44925
• 关键词: Respicorder; device; development

Chronic respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD) cause a significant burden to those affected and health system expenditure. There is a great need for new and wider deployment of diagnostics, well recognised by patient charity groups, clinician societies, and healthcare evidence appraisers. This could help identify diseases earlier, personalise treatment plans, and help manage the disease proactively. It has long been known that most of the cost and suffering from these diseases come from short-term attacks or exacerbations. It is more recent that asthma and COPD have been understood to be 'umbrella' terms for a number of disease sub-types, that behave like different diseases.Arete is developing a multi-test diagnostic device for lung conditions. While such a device has been proposed before, no such devices have made it to the market. Our product could widen access and frequency to clinical-grade diagnostic tests, giving doctors better information to help manage their patients and reducing overall costs to the NHS and other health systems.This project is to further develop the physical device, and in particular its ability to efficiently and effectively change between testing modes. This development is critical to the performance of the device and future commercial growth of Arete Medical Technologies.The project will consider the design requirements for the device. The device will then be specified, designed, and prototyped to meet these requirements. Thirdly, the device will be tested to ensure it meets the requirements. At this stage, the device should be ready to be used in initial clinical studies. Public funding for this project will increase R&D jobs within the project budget and position the company for further growth on successful completion.

哮喘和慢性阻塞性肺病等慢性呼吸道疾病给患者和卫生系统支出造成了沉重负担。非常需要新的和更广泛的诊断部署，并得到患者慈善团体，临床医师协会和医疗保健证据评估师的认可。这可以帮助更早地识别疾病，个性化治疗计划，并帮助主动管理疾病。人们早就知道，这些疾病的大部分费用和痛苦来自短期发作或恶化。最近，哮喘和COPD被认为是许多疾病亚型的“总括”术语，表现为不同的疾病。Arete正在开发一种用于肺部疾病的多测试诊断设备。虽然之前已经提出了这样的设备，但是没有这样的设备进入市场。我们的产品可以扩大临床级诊断测试的访问和频率，为医生提供更好的信息，以帮助管理他们的病人，并降低NHS和其他卫生系统的整体成本。该项目是进一步开发物理设备，特别是其在测试模式之间高效转换的能力。这一发展对设备的性能和Arete Medical Technologies未来的商业增长至关重要。该项目将考虑设备的设计要求。然后将对器械进行指定、设计和原型制作，以满足这些要求。第三，将对设备进行测试，以确保其符合要求。在此阶段，器械应准备好用于初始临床研究。该项目的公共资金将在项目预算内增加研发工作，并使公司在成功完成后进一步增长。